# Aura Biosciences, Inc.: Form SC 13D/A, filed Nov 9, 2023

- Company: [Aura Biosciences, Inc.](/companies/aura.md) (CIK 1501796)
- Form: SC 13D/A
- Filed: 2023-11-09
- Accepted by EDGAR: Nov 9, 2023, 16:34 ET
- Period: not reported
- Accession: 0000902664-23-005428
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1501796/000090266423005428/p23-2746sc13da.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1501796/000090266423005428/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1501796/000090266423005428/p23-2746sc13da.htm

Filed Nov 9, 2023.
Source: SEC EDGAR, the filing index for accession 0000902664-23-005428. Last ingested by Listed: Oct 27, 2026, 17:26 ET. No prices; not investment advice.
